Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie L Graff

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Current Treatment Options in Oncology|October 3, 2024
Updates in Systemic Treatment of Hormone Receptor-Positive Early-Stage Breast CancerEmily Hsu, Sabrina M Arezo, Stephanie L Graff
Chinese Clinical Oncology|January 6, 2026
Metronomic capecitabine plus aromatase inhibitor as initial therapy in HR-positive HER2-negative metastatic breast cancer: a low-cost and easily implementable optionDana Narvaez, Gerneiva T Parkinson, Stephanie L Graff
Journal of the Advanced Practitioner in Oncology|September 19, 2024
Improving Outcomes for Women With Metastatic HER<sub>2</sub>-Positive and HER<sub>2</sub>-Low Breast CancerStephanie L Graff, Christine McGinn, Jeanine R Showalter
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 20, 2026
Paired Tissue and ctDNA Profiling Reveals Novel ESR1 Amplifications CDK4/6 Resistance Mechanisms in HR+/HER2- Metastatic Breast CancersLiu Liu, Stephanie L Graff, Liang Cheng, et al.
Chinese Clinical Oncology|August 13, 2023
Sequencing systemic therapy in hormone-receptor positive metastatic breast cancer: a modern paradigmStephanie A Haddad, Don S Dizon, Stephanie L Graff
Histopathology|December 17, 2024
Recent advancements in biomarkers and molecular diagnostics in hormonal receptor-positive breast cancerYihong Wang, Liu Liu, Stephanie L Graff, et al.
Histopathology|October 22, 2024
Locoregional event or dyssynchronous distant metastasis: clinicopathological and molecular analysis of contralateral axillary lymph node metastasis in breast cancer patientsYihong Wang, Liu Liu, Stephanie L Graff, et al.
Journal of Women'S Health (2002)|November 8, 2019
Gender-Specific Conferences and Symposia: A Putative Support Structure for Female PhysiciansNicole C Woitowich, Stephanie L Graff, Mamta Swaroop, et al.
Histopathology|February 10, 2026
Genomic and clinicopathological characteristics of low oncotype recurrent score breast cancers with subsequent metastasisLiu Liu, Stephanie L Graff, Sean Hacking, et al.
JCO Oncology Practice|July 12, 2020
Increase in Genetic Counseling and Testing Referrals After Breast Cancer Pathway ImplementationStephanie L Graff, Jared M Holder, Lindsay E Sears, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Current Treatment Options in Oncology|October 3, 2024
Updates in Systemic Treatment of Hormone Receptor-Positive Early-Stage Breast CancerEmily Hsu, Sabrina M Arezo, Stephanie L Graff
Chinese Clinical Oncology|January 6, 2026
Metronomic capecitabine plus aromatase inhibitor as initial therapy in HR-positive HER2-negative metastatic breast cancer: a low-cost and easily implementable optionDana Narvaez, Gerneiva T Parkinson, Stephanie L Graff
Journal of the Advanced Practitioner in Oncology|September 19, 2024
Improving Outcomes for Women With Metastatic HER<sub>2</sub>-Positive and HER<sub>2</sub>-Low Breast CancerStephanie L Graff, Christine McGinn, Jeanine R Showalter
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 20, 2026
Paired Tissue and ctDNA Profiling Reveals Novel ESR1 Amplifications CDK4/6 Resistance Mechanisms in HR+/HER2- Metastatic Breast CancersLiu Liu, Stephanie L Graff, Liang Cheng, et al.
Chinese Clinical Oncology|August 13, 2023
Sequencing systemic therapy in hormone-receptor positive metastatic breast cancer: a modern paradigmStephanie A Haddad, Don S Dizon, Stephanie L Graff
Histopathology|December 17, 2024
Recent advancements in biomarkers and molecular diagnostics in hormonal receptor-positive breast cancerYihong Wang, Liu Liu, Stephanie L Graff, et al.
Histopathology|October 22, 2024
Locoregional event or dyssynchronous distant metastasis: clinicopathological and molecular analysis of contralateral axillary lymph node metastasis in breast cancer patientsYihong Wang, Liu Liu, Stephanie L Graff, et al.
Journal of Women'S Health (2002)|November 8, 2019
Gender-Specific Conferences and Symposia: A Putative Support Structure for Female PhysiciansNicole C Woitowich, Stephanie L Graff, Mamta Swaroop, et al.
Histopathology|February 10, 2026
Genomic and clinicopathological characteristics of low oncotype recurrent score breast cancers with subsequent metastasisLiu Liu, Stephanie L Graff, Sean Hacking, et al.
JCO Oncology Practice|July 12, 2020
Increase in Genetic Counseling and Testing Referrals After Breast Cancer Pathway ImplementationStephanie L Graff, Jared M Holder, Lindsay E Sears, et al.
Pageof 7